QDEL

QuidelOrtho Corporation NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · quidelortho.com

$12.64

Mkt Cap $857.0M

52w Low $10.86 6.3% of range 52w High $38.99

50d MA $17.16 200d MA $24.95

P/E (TTM) -0.8x

EV/EBITDA -9.5x

P/B 0.5x

Debt/Equity 1.5x

ROE -58.9%

P/FCF -23.9x

RSI (14) —

ATR (14) —

Beta 0.92

50d MA $17.16

200d MA $24.95

Avg Volume 2.0M

About

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 11, 2026	AMC	0.43	0.46	+7.0%	28.80	-7.4%	-17.6%	-18.1%	-19.7%	-16.1%	-18.0%	-40.6%	—
Nov 5, 2025	AMC	0.51	0.80	+56.9%	27.37	-3.3%	-22.3%	-25.6%	-27.9%	-20.0%	-17.5%	+1.4%	—
Aug 5, 2025	AMC	0.56	0.12	-78.6%	23.68	+15.1%	-1.0%	+3.0%	+1.0%	-0.2%	+6.4%	+17.4%	—
May 7, 2025	AMC	0.58	0.74	+27.6%	25.85	+10.9%	+41.0%	+40.6%	+44.8%	+37.4%	+29.8%	+14.2%	—
Feb 12, 2025	AMC	0.55	0.63	+14.5%	39.94	+9.7%	+4.3%	+1.6%	+3.9%	+4.9%	+2.7%	-9.6%	—
Nov 7, 2024	AMC	0.31	0.85	+174.2%	38.85	+7.5%	+12.6%	+10.6%	+5.9%	+3.0%	+0.3%	+4.3%	—
Jul 31, 2024	AMC	-0.21	-0.07	+66.7%	39.29	+6.5%	+6.9%	+6.9%	+3.3%	+2.0%	+0.8%	+7.5%	—
May 8, 2024	AMC	0.43	0.44	+2.3%	42.68	-0.1%	+2.2%	-0.2%	-1.3%	+3.5%	+5.3%	-2.4%	—
Feb 13, 2024	AMC	2.02	1.17	-42.1%	66.77	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%	-28.9%	—
Nov 1, 2023	AMC	0.45	0.90	+100.0%	60.50	+2.6%	+3.7%	+6.2%	+3.9%	+1.8%	-0.3%	+14.4%	—
Aug 8, 2023	AMC	0.25	0.26	+4.0%	82.26	-3.0%	-7.3%	-5.9%	-5.3%	-7.2%	-9.2%	-8.0%	—
May 3, 2023	AMC	1.40	1.80	+28.6%	93.23	-0.6%	-6.5%	-5.0%	-5.3%	-7.7%	-6.5%	-7.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 10	UBS	Maintains	Neutral → Neutral	—	$14.15	$14.08	-0.5%	-2.1%	+13.6%	+22.4%	+23.6%	-10.3%
Feb 12	Citigroup	Maintains	Neutral → Neutral	—	$28.80	$26.68	-7.4%	-17.6%	-18.1%	-19.7%	-16.1%	-18.0%
Jan 21	UBS	Maintains	Neutral → Neutral	—	$32.73	$32.20	-1.6%	-10.1%	-6.6%	-14.2%	-12.4%	-16.7%
Nov 7	JP Morgan	Maintains	Underweight → Underweight	—	$21.26	$21.01	-1.2%	-4.3%	-7.2%	+3.0%	+6.3%	+4.3%
Nov 6	UBS	Maintains	Neutral → Neutral	—	$27.37	$26.48	-3.3%	-22.3%	-25.6%	-27.9%	-20.0%	-17.5%
Oct 7	Citigroup	Downgrade	Buy → Neutral	—	$29.60	$28.45	-3.9%	-6.4%	-5.9%	-5.2%	-10.9%	-11.1%
Aug 7	UBS	Maintains	Neutral → Neutral	—	$23.44	$23.44	+0.0%	+4.1%	+2.0%	+0.9%	+7.5%	+15.5%
Aug 6	Citigroup	Maintains	Buy → Buy	—	$23.68	$27.26	+15.1%	-1.0%	+3.0%	+1.0%	-0.2%	+6.4%
May 8	Jefferies	Upgrade	Hold → Buy	—	$25.85	$28.66	+10.9%	+41.0%	+40.6%	+44.8%	+37.4%	+29.8%
May 8	UBS	Maintains	Neutral → Neutral	—	$25.85	$28.66	+10.9%	+41.0%	+40.6%	+44.8%	+37.4%	+29.8%
Apr 21	JP Morgan	Maintains	Underweight → Underweight	—	$25.17	$24.74	-1.7%	-2.4%	-2.8%	+2.2%	+10.4%	+11.6%
Feb 13	RBC Capital	Maintains	Outperform → Outperform	—	$39.94	$43.80	+9.7%	+4.3%	+1.6%	+3.9%	+4.9%	+2.7%
Feb 13	UBS	Maintains	Neutral → Neutral	—	$39.94	$43.80	+9.7%	+4.3%	+1.6%	+3.9%	+4.9%	+2.7%
Dec 11	Citigroup	Upgrade	Neutral → Buy	—	$38.50	$39.65	+3.0%	+7.8%	+8.1%	+7.4%	+13.9%	+11.8%
Aug 16	RBC Capital	Maintains	Outperform → Outperform	—	$44.65	$44.46	-0.4%	-1.6%	+0.7%	-2.0%	-2.9%	-2.9%
Aug 1	RBC Capital	Maintains	Outperform → Outperform	—	$39.29	$41.84	+6.5%	+6.9%	+6.9%	+3.3%	+2.0%	+0.8%
May 9	RBC Capital	Maintains	Outperform → Outperform	—	$42.68	$42.65	-0.1%	+2.2%	-0.2%	-1.3%	+3.5%	+5.3%
Mar 4	UBS	Downgrade	Neutral → Sell	—	$45.53	$44.13	-3.1%	-2.6%	-5.7%	-5.8%	-1.8%	+1.6%
Feb 14	Craig-Hallum	Downgrade	Buy → Hold	—	$66.77	$46.27	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%
Feb 14	JP Morgan	Downgrade	Neutral → Underweight	—	$66.77	$46.27	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%
Feb 14	RBC Capital	Maintains	Outperform → Outperform	—	$66.77	$46.27	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%
Feb 14	Raymond James	Downgrade	Strong Buy → Outperform	—	$66.77	$46.27	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%
Feb 14	William Blair	Downgrade	Outperform → Market Perform	—	$66.77	$46.27	-30.7%	-32.2%	-34.1%	-37.5%	-30.2%	-25.9%
Dec 21	RBC Capital	Maintains	Outperform → Outperform	—	$70.96	$72.26	+1.8%	+4.0%	+4.3%	+6.1%	+6.3%	+5.7%
Dec 11	Citigroup	Downgrade	Buy → Neutral	—	$66.02	$65.79	-0.3%	-0.4%	-0.7%	+6.9%	+9.5%	+7.6%
Nov 2	Raymond James	Maintains	Strong Buy → Strong Buy	—	$60.50	$62.10	+2.6%	+3.7%	+6.2%	+3.9%	+1.8%	-0.3%
Sep 19	RBC Capital	Maintains	Outperform → Outperform	—	$75.04	$75.11	+0.1%	+1.0%	-2.1%	-4.3%	-4.5%	-4.6%
Aug 15	Raymond James	Maintains	Strong Buy → Strong Buy	—	$76.34	$75.42	-1.2%	-2.1%	-5.7%	-4.0%	-2.7%	+0.3%
Aug 9	RBC Capital	Maintains	Outperform → Outperform	—	$82.26	$79.80	-3.0%	-7.3%	-5.9%	-5.3%	-7.2%	-9.2%
Aug 9	JP Morgan	Maintains	Neutral → Neutral	—	$82.26	$79.80	-3.0%	-7.3%	-5.9%	-5.3%	-7.2%	-9.2%
May 4	RBC Capital	Maintains	Outperform → Outperform	—	$93.23	$92.70	-0.6%	-6.5%	-5.0%	-5.3%	-7.7%	-6.5%
Feb 16	RBC Capital	Maintains	Outperform → Outperform	—	$86.23	$87.00	+0.9%	+5.7%	+6.0%	+4.0%	+4.2%	+2.9%
Feb 16	Raymond James	Maintains	Strong Buy → Strong Buy	—	$86.23	$87.00	+0.9%	+5.7%	+6.0%	+4.0%	+4.2%	+2.9%
Dec 12	Citigroup	Upgrade	Neutral → Buy	—	$92.30	$95.00	+2.9%	+5.6%	-11.1%	-8.5%	-6.7%	-10.5%
Nov 3	JP Morgan	Maintains	Neutral → Neutral	—	$88.73	$85.51	-3.6%	-1.4%	+2.3%	-0.2%	-1.2%	-1.2%
Oct 14	UBS	Upgrade	Sell → Neutral	—	$74.60	$75.87	+1.7%	+2.3%	+3.6%	+9.0%	+4.4%	+5.5%
May 6	Raymond James	Maintains	Strong Buy → Strong Buy	—	$102.66	$103.64	+1.0%	-4.3%	-10.2%	-10.9%	-13.2%	-9.9%
Feb 22	Raymond James	Upgrade	Outperform → Strong Buy	—	$97.84	$99.30	+1.5%	+5.4%	+5.4%	+6.7%	+10.1%	+8.1%
Aug 6	Raymond James	Maintains	Outperform → Outperform	—	$144.00	$129.16	-10.3%	-13.2%	-9.8%	-9.6%	-11.9%	-13.4%
Jun 28	Raymond James	Maintains	Outperform → Outperform	—	$119.09	$119.08	-0.0%	+6.7%	+10.9%	+7.6%	+8.0%	+5.2%
Jun 17	Craig-Hallum	Maintains	Buy → Buy	—	$112.03	$111.13	-0.8%	+0.7%	+1.6%	-0.2%	-0.8%	+0.7%
Jun 4	JP Morgan	Maintains	Underweight → Underweight	—	$107.84	$106.50	-1.2%	-3.5%	+1.3%	+3.6%	+4.2%	+7.3%
May 7	Raymond James	Maintains	Outperform → Outperform	—	$108.54	$108.34	-0.2%	+11.4%	+7.2%	+5.7%	+10.5%	+7.3%
Mar 11	Craig-Hallum	Maintains	Buy → Buy	—	$130.01	$134.07	+3.1%	+3.3%	+4.8%	+8.5%	+6.8%	+9.8%
Mar 11	Raymond James	Maintains	Outperform → Outperform	—	$130.01	$134.07	+3.1%	+3.3%	+4.8%	+8.5%	+6.8%	+9.8%
Feb 19	Raymond James	Maintains	Outperform → Outperform	—	$210.10	$193.07	-8.1%	-13.1%	-22.2%	-20.3%	-18.1%	-20.9%
Jan 22	Raymond James	Upgrade	Market Perform → Outperform	—	$218.49	$222.59	+1.9%	+6.9%	+9.2%	+3.5%	+2.6%	+4.0%
Jul 8	Piper Sandler	Maintains	Overweight → Overweight	—	$224.98	$228.97	+1.8%	+5.6%	+8.9%	+9.6%	+4.2%	+6.6%
May 12	JP Morgan	Downgrade	Neutral → Underweight	—	$208.95	$207.89	-0.5%	-12.6%	-14.5%	-11.1%	-5.6%	-12.5%
Mar 26	Barclays	Downgrade	Overweight → Equal Weight	—	$80.69	$79.97	-0.9%	+10.3%	+16.9%	+28.4%	+21.2%	+21.2%